Cost-effectiveness analysis of interferon as adjunvant therapy in high-risk melanoma patients in Spain

J.L. González-Larriba; S. Serrano; M. Álvarez-Mon; F. Camacho; M.A. Casado; J.L. Díaz-Pérez; E. Díaz Rubio; L. Fosbrook; V. Guillem; J.J. López López; J. Toribio

Cost-effectiveness analysis of interferon as adjunvant therapy in high-risk melanoma patients in Spain

J.L. González-Larriba, S. Serrano, M. Álvarez-Mon, F. Camacho, M.A. Casado, J.L. Díaz-Pérez, E. Díaz Rubio, L. Fosbrook, V. Guillem, J.J. López López, J. Toribio

Departamento de Ciencias Morfológicas

Producción científica: Contribución a una revista › Artículo › Investigación

Idioma original	Inglés
Páginas (desde-hasta)	2344-2352
Publicación	Eur. J. Cancer
Volumen	36
N.º	18
Estado	Publicada - 1 dic 2000

Citar esto

@article{7f6f8504a47348fa965749aea4ab933b,

title = "Cost-effectiveness analysis of interferon as adjunvant therapy in high-risk melanoma patients in Spain",

author = "J.L. Gonz{\'a}lez-Larriba and S. Serrano and M. {\'A}lvarez-Mon and F. Camacho and M.A. Casado and J.L. D{\'i}az-P{\'e}rez and \{D{\'i}az Rubio\}, E. and L. Fosbrook and V. Guillem and \{L{\'o}pez L{\'o}pez\}, J.J. and J. Toribio",

year = "2000",

month = dec,

day = "1",

language = "English",

volume = "36",

pages = "2344--2352",

journal = "Eur. J. Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "18",

}

TY - JOUR

T1 - Cost-effectiveness analysis of interferon as adjunvant therapy in high-risk melanoma patients in Spain

AU - González-Larriba, J.L.

AU - Serrano, S.

AU - Álvarez-Mon, M.

AU - Camacho, F.

AU - Casado, M.A.

AU - Díaz-Pérez, J.L.

AU - Díaz Rubio, E.

AU - Fosbrook, L.

AU - Guillem, V.

AU - López López, J.J.

AU - Toribio, J.

PY - 2000/12/1

Y1 - 2000/12/1

M3 - Article

SN - 0959-8049

VL - 36

SP - 2344

EP - 2352

JO - Eur. J. Cancer

JF - Eur. J. Cancer

IS - 18

ER -